{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "3135674",
  "DateCompleted": {
    "Year": "1988",
    "Month": "09",
    "Day": "02"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "ger"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0303-657X",
      "JournalIssue": {
        "Volume": "170",
        "Issue": "2",
        "PubDate": {
          "Year": "1988"
        }
      },
      "Title": "Zeitschrift fur Erkrankungen der Atmungsorgane",
      "ISOAbbreviation": "Z Erkr Atmungsorgane"
    },
    "ArticleTitle": "[Bronchopulmonary infections in mucoviscidosis].",
    "Pagination": {
      "StartPage": "201",
      "EndPage": "211",
      "MedlinePgn": "201-11"
    },
    "Abstract": {
      "AbstractText": [
        "Cystic fibrosis (CF) is the most common genetic disease of Caucasians and also the most important lung disease of the first decades of life associated with infections by a variety of bacteria species especially Pseudomonas aeruginosa and Staphylococcus aureus. During the last two decades chronic Pseudomonas infection has emerged as the most difficult problem. Pseudomonas bacteria are able to synthesize numerous extracellular factors (virulence factors) contributing to its pathogenicity. Immunological defense mechanisms against Pseudomonas (and other bacteria species) have been demonstrated, but a complete elimination from infected lungs has not been observed. Therapy of Pseudomonas infections includes frequently combinations of antibiotics of the beta-lactam and aminoglycoside type."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Kinderheilkunde der Wilhelm-Pieck-Universit\u00e4t Rostock, DDR."
          }
        ],
        "LastName": "Hein",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wiersbitzky",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wunderlich",
        "ForeName": "P",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Bronchopulmonale Infektionen bei Mukoviszidose."
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Z Erkr Atmungsorgane",
    "NlmUniqueID": "7503239",
    "ISSNLinking": "0303-657X"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Cystic Fibrosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Opportunistic Infections"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Pneumonia"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Pseudomonas Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Pseudomonas aeruginosa"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ],
  "NumberOfReferences": "32"
}